Condition
Hard to Heal Wounds
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 2 (1)
Trial Status
Completed2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07235254Not ApplicableNot Yet Recruiting
A RCT of Moist Ag Dressing in Chronic Wound
NCT07050667Not ApplicableCompletedPrimary
Treatment of Chronic Wounds With Cold Plasma -Plasma Care® vs. Placebo
NCT02020746Phase 2CompletedPrimary
Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds
NCT01772303Early Phase 1UnknownPrimary
Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds
Showing all 4 trials